AbbVie Uses Intel AI Tech to Improve Research Translations

Global biopharmaceutical company AbbVie is leveraging artificial intelligence (AI) and natural language processing (NLP) for research translation, improving collaboration and search capabilities to enable the discovery of new treatments for patients.